**Patient Discharge Summary**

**Patient Information**

* Name: Jane Doe
* Date of Birth: March 12, 1990
* Gender: Female
* Address: 123 Main St, Anytown, USA
* Phone Number: 555-555-5555

**Admission Information**

* Date of Admission: January 10, 2023
* Time of Admission: 10:00 AM
* Unit: Infectious Diseases
* Diagnosis: Influenza (H3N2)

**Medical History**

* Prior medical conditions: None
* Allergies: None
* Medications: None

**Clinical Course**

Jane Doe was admitted to the Infectious Diseases unit on January 10, 2023, with a chief complaint of fever, cough, and body aches for 3 days. She reported worsening symptoms over the past 24 hours, including difficulty breathing and chest tightness. On admission, her vital signs were:

* Temperature: 102.5Â°F
* Pulse: 110 beats per minute
* Blood Pressure: 120/80 mmHg
* Respiratory Rate: 24 breaths per minute
* Oxygen Saturation: 92% on room air

**Diagnostic Testing**

* Rapid Antigen Test (RAT): Positive for Influenza A
* Real-Time Polymerase Chain Reaction (RT-PCR) Test: Positive for Influenza A (H3N2)
* Chest X-ray: Interstitial infiltrates consistent with primary influenza pneumonia
* Pulse Oximetry: 92% on room air

**Therapy**

* Antiviral therapy was started with Oseltamivir 75 mg orally twice a day, given the patient's age and severity of symptoms.
* Antipyretics were administered as needed, including acetaminophen 325 mg every 6 hours as needed.
* Rest and hydration were encouraged to manage symptoms.
* Inhaled bronchodilators were not used due to the patient's normal spirometry results.

**Complications**

* The patient developed mild hypoxemia, which was managed with supplemental oxygen via nasal cannula.

**Discharge Instructions**

* Continue Oseltamivir 75 mg orally twice a day for the next 5 days.
* Take acetaminophen 325 mg every 6 hours as needed for fever and body aches.
* Drink plenty of fluids to stay hydrated.
* Rest and avoid strenuous activities for the next 7-10 days.
* Follow up with primary care physician in 1 week for further evaluation and management.

**Medications**

* Oseltamivir 75 mg orally twice a day for 5 days
* Acetaminophen 325 mg every 6 hours as needed
* Oxygen via nasal cannula as needed

**Follow-up**

* Follow-up appointment with primary care physician: January 17, 2023
* Phone follow-up: January 14, 2023, to assess symptoms and adjust therapy as needed.

**Discharge Summary**

Jane Doe was discharged from the Infectious Diseases unit on January 15, 2023, with a diagnosis of influenza (H3N2) and a plan for antiviral therapy and symptom management. She was instructed to continue taking Oseltamivir and acetaminophen as directed, and to follow up with her primary care physician in 1 week.